NCT07656987Completed
Effects of Different Doses of Virtual Reality Therapy in Chronic Stroke Patients
Comparison of the Effects of Different Doses of Virtual Reality Therapy on Motor Functions in Chronic Stroke Patients - A Randomized Controlled Single-Blind Study
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
This study aimed to compare the effects of different doses of Wii Fit-based virtual reality (VR) therapy added to conventional rehabilitation in patients with chronic stroke. Forty-three patients were randomly assigned to three groups: a control group receiving conventional rehabilitation only (5 days/week, 45 min/session for 4 weeks), a VR3 group receiving conventional rehabilitation plus VR training three days per week (20 min/session, 12 sessions total), and a VR5 group receiving conventional rehabilitation plus VR training five days per week (20 min/session, 20 sessions total). Balance (Berg Balance Scale), functional independence (Functional Independence Measure), stroke-specific quality of life (SS-QOL), static postural alignment (Becure Posture Mobile), and center of pressure measurements (Becure Balance System) were assessed before treatment (T0), after treatment (T1), and at one-month follow-up (T2). This prospective, single-blind, randomized controlled trial was conducted at Istanbul Physical Medicine Rehabilitation Training and Research Hospital.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 43 (actual)
- First submitted
- 16 Jun 2026
- Start date
- 15 Aug 2025
- Primary completion date
- 10 Apr 2026
- Lead sponsor
- Istanbul Physical Medicine Rehabilitation Training and Research Hospital
- Diseases
- Stroke
- NCT number
- NCT07656987
What you commit to
- Study type: Interventional
- Participants enrolled: 43
- From 15 Aug 2025 to the primary completion date, 10 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of epilepsy
- Visual and/or hearing impairment at a level that would affect participation in treatment methods
Other
- Mini-Mental State Examination (MMSE) score \< 18
- Diagnosis of intellectual disability
Who the study is looking for
- Diagnosis of ischemic or hemorrhagic stroke confirmed by CT or MRI
- Chronic stroke (onset ≥ 6 months prior to enrollment)
- Age between 20 and 75 years
- Mini-Mental State Examination (MMSE) score ≥ 18 (or MMSE-E for illiterate patients)
- Willingness to participate and provide written informed consent
Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Physical Medicine Rehabilitation Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.